股票交易异常波动
Search documents
直真科技:股票交易异常波动
news flash· 2025-07-28 09:56
直真科技(003007)公告,公司股票于2025年7月25日、7月28日连续2个交易日收盘价格涨幅偏离值累 计超过20%,属于股票交易异常波动。公司正在筹划向特定对象发行股票事项,后续实施尚存在不确定 性。此外,公司不存在其他关于公司的应披露而未披露的重大事项,或处于筹划阶段的重大事项。公司 近期经营情况正常及内外部经营环境未发生重大变化。股票异常波动期间,公司控股股东、实际控制人 不存在买卖公司股票的情形。 ...
阿石创:公司股票交易异常波动
news flash· 2025-07-28 09:41
Core Viewpoint - The company, Astone Technology (300706), announced that its stock price experienced a cumulative deviation of 30.04% over two consecutive trading days (July 25, 2025, and July 28, 2025) [1] Summary by Relevant Sections - The company confirmed that there are no additional or corrective disclosures needed regarding previously released information [1] - No significant undisclosed material information has been reported in public media that could have impacted the stock trading price [1] - The company's current operational status is normal, with no significant changes expected in the internal or external business environment [1] - During the period of unusual stock price fluctuations, the company, its controlling shareholders, actual controllers, directors, and senior management have not engaged in buying or selling the company's stock [1]
和泰机电:公司未参与雅鲁藏布江下游水电工程项目建设
news flash· 2025-07-28 08:28
Core Viewpoint - The company, HeTai Machinery and Electrical (001225), has experienced a significant stock price fluctuation, with a cumulative increase of over 20% over three consecutive trading days in July 2025, indicating abnormal trading activity [1] Company Operations - The company's current operating conditions are normal, and there have been no significant changes in its main business operations [1] - There are no major changes in the internal and external operating environment of the company [1] - The company, along with its controlling shareholders and actual controllers, has no undisclosed significant matters related to the company [1] Project Involvement - The company has not participated in the construction of the Yarlung Tsangpo River downstream hydropower project [1]
易明医药: 股票交易异常波动公告暨风险提示公告
Zheng Quan Zhi Xing· 2025-07-27 16:13
Group 1 - The company, Tibet Yiming Xiya Pharmaceutical Technology Co., Ltd., announced a significant change in control due to a share transfer agreement signed between the controlling shareholder Gao Fan and Beijing Fuhai, involving the transfer of 43,855,883 shares, which represents a substantial portion of the company's total shares [3][4]. - The company's stock experienced abnormal trading fluctuations, with a cumulative price deviation exceeding 20% over three consecutive trading days from July 23 to July 25, 2025 [2]. - The board of directors confirmed that there are no undisclosed significant matters or ongoing negotiations that would require disclosure under the Shenzhen Stock Exchange regulations, ensuring transparency in the company's operations [4][5]. Group 2 - The company is currently in the process of preparing its semi-annual report, and as of now, it has not reached the threshold that would necessitate a performance forecast disclosure according to the Shenzhen Stock Exchange rules [5]. - The company will continue to adhere strictly to legal and regulatory requirements regarding information disclosure and will ensure timely updates to stakeholders [4].
深水规院: 关于股票交易异常波动及严重异常波动公告
Zheng Quan Zhi Xing· 2025-07-24 16:33
Group 1 - The company's stock experienced a significant price fluctuation, with a cumulative price deviation exceeding 30% over two consecutive trading days on July 23 and 24, 2025, indicating abnormal trading activity [1][2] - The stock's price deviation exceeded 100% over four consecutive trading days from July 21 to July 24, 2025, categorizing it as severe abnormal trading activity [2] - The company's current price-to-earnings (P/E) ratio stands at 170.26, which is substantially higher than the industry average P/E ratio of 36.95 for the "Professional Technical Services" sector [1][2] Group 2 - The company provides professional technical services including surveying design, planning consultation, and project management, holding various qualifications in the hydropower sector [2] - The company is closely monitoring the Yaxia Hydropower Station project but has not participated in its construction [2] - The board confirmed that there are no undisclosed significant matters or risks that could impact the company's stock price [2]
西子清洁能源装备制造股份有限公司股票交易异常波动公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-07-23 23:19
Group 1 - The company's stock (Xizi Clean Energy Equipment Manufacturing Co., Ltd.) experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 20% over three consecutive trading days (July 21, 2025, July 22, 2025, and July 23, 2025) [2] - The company conducted an internal review and confirmed that there were no undisclosed significant information affecting the stock price, and no major changes in the company's operational situation or external environment [3][5] - The company and its major shareholders did not engage in any trading of the company's stock during the period of abnormal fluctuation [3] Group 2 - The company confirmed that there are no undisclosed matters that should be disclosed according to the Shenzhen Stock Exchange's listing rules, and previous disclosures do not require correction or supplementation [5] - The company has previously disclosed its 2025 half-year performance forecast on July 11, 2025, and plans to release its 2025 half-year report on August 26, 2025 [6]
*ST亚振股价持续异动 监管核查存异常交易行为
Zheng Quan Ri Bao Zhi Sheng· 2025-07-23 17:10
Core Viewpoint - The company *ST Yanzhen is facing significant financial challenges, with expected losses in the first half of 2025, while its stock has experienced unusual trading activity and volatility, leading to regulatory scrutiny [1][5]. Group 1: Financial Performance - The company reported a net profit of -1.17 billion in 2024, with a first-quarter net profit of -213.14 million [5]. - For the first half of 2025, the company anticipates a net loss ranging from -330 million to -395 million, with a net loss excluding non-recurring items expected between -320 million and -380 million [5]. Group 2: Stock Trading Activity - The stock of *ST Yanzhen has been subject to abnormal trading fluctuations, with a cumulative price deviation of 14.42% from July 21 to July 23, and a total trading volume of 11.5755 million shares, amounting to 277 million [1]. - Following the implementation of delisting risk warnings, the stock price increased significantly, achieving 31 limit-up days and a total increase of 308.99% from May 6 to July 23 [2]. Group 3: Regulatory Actions - The company has undergone three trading suspensions this year due to significant price deviations, with the latest suspension occurring from July 16 to July 18 [3]. - The Shanghai Stock Exchange has intervened to maintain market order, emphasizing the importance of adhering to trading rules and preventing market chaos [2]. Group 4: Corporate Changes - In May 2025, the company's control changed hands, with Wu Tao becoming the new controlling shareholder, while no significant changes to the company's main business or asset plans are anticipated in the next 12 months [4].
3连板韩建河山:PCCP的销售合同主要通过投标方式取得 存在投标而不能中标的风险
news flash· 2025-07-23 11:02
Core Viewpoint - The company, Han Jian He Shan, has experienced a significant stock price fluctuation, with a cumulative increase of 20% over three consecutive trading days, indicating abnormal trading activity [1] Company Summary - Han Jian He Shan's main business involves the production and manufacturing of prestressed concrete pipes (PCCP) [1] - The sales contracts for PCCP are primarily obtained through a bidding process, which is subject to competitive market conditions [1] - The company has stated that its production and operations are normal, and there have been no significant changes in the internal or external business environment [1] Industry Summary - The industry in which Han Jian He Shan operates is characterized by intense competition, leading to risks associated with the possibility of not winning bids [1]
*ST高鸿: 关于股票交易异常波动的公告
Zheng Quan Zhi Xing· 2025-07-22 11:14
Summary of Key Points Core Viewpoint - The company, 大唐高鸿网络股份有限公司, is currently facing significant legal and regulatory challenges, including a stock price decline and ongoing investigations by the China Securities Regulatory Commission (CSRC) related to alleged information disclosure violations [1][2][5]. Group 1: Stock Trading and Regulatory Issues - The company's stock experienced a cumulative decline of over 12% over three consecutive trading days, triggering an abnormal trading situation as per Shenzhen Stock Exchange regulations [1]. - The CSRC issued a notice of investigation to the company on July 30, 2024, due to suspected violations of information disclosure laws [2][5]. - As of the announcement date, the investigation by the CSRC is still ongoing, and the company has not received any conclusive opinions or decisions regarding the investigation [2][5]. Group 2: Legal Proceedings - The company is involved in multiple legal disputes, including nine lawsuits initiated by 京大唐高鸿科技发展有限公司, with the company having lost in the first instance and subsequently appealing [2]. - The company has received a total of 12 civil rulings related to these lawsuits, which are similar in nature to previously filed cases [2][3]. - As of February 12, 2025, the company's bank accounts have been frozen, with a total of approximately 140 million yuan executed by the court, leaving around 16.7 million yuan unfrozen [3]. Group 3: Financial Reporting and Audit Opinions - The company has faced audit challenges, with auditors issuing a disclaimer of opinion for the financial statements from 2021 to 2023, indicating uncertainty regarding the company's ability to continue as a going concern [6]. - The company’s stock has been subjected to risk warnings due to continuous losses and audit opinions that raise concerns about its financial health [6]. - The company plans to disclose its half-year report for 2025 on August 29, 2025, which will provide further insights into its operational and financial status [6].
成都先导: 成都先导药物开发股份有限公司股票交易异常波动公告
Zheng Quan Zhi Xing· 2025-07-21 12:08
证券代码:688222 证券简称:成都先导 公告编号:2025-028 成都先导药物开发股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 所科创板股票异常交易实时监控细则》的有关规定,属于股票交易异常波动。 公司股票交易连续 3 个交易日内(2025 年 7 月 17 日、2025 年 7 月 18 日和 2025 年 7 月 21 日)收盘价格涨幅偏离值累计达到 30%,根据《上海证券交易所交易规 则》、 《上海证券交易所科创板股票异常交易实时监控细则》的有关规定,属于股票 交易异常波动。 二、公司关注并核实的相关情况 行业政策未发生重大调整,生产成本和销售等情况未出现大幅波动、内部生产经营 秩序正常。 不存在正在筹划并购重组、股份发行、债务重组、业务重组、资产剥离和资产注入 等重大事项。公司无应披露而未披露的重大信息。 市场传闻,未发现其他可能对公司股价产生较大影响的重大事件;未发现公司及有 关人员泄露未公开重大信息的情况。 公司董事、监事、高级管理人员不存在买卖公司股 ...